Concepedia

Stamatis Papathanasiou

SP

Statistics

Publications

7

Citations

997

H-Index

7

Active since

2015

Affiliations

Harvard University(Current)

Boston VA Research Institute

Howard Hughes Medical Institute

Dana-Farber Cancer Institute

Harvard Stem Cell Institute

Stamatis Papathanasiou is an author at Harvard University specializing in life sciences, genetics, and crispr-cas systems.

ORCID

Publications per year

2015–2023

7

Publications

7

Chromothripsis as an on-target consequence of CRISPR–Cas9 genome editing

Mitchell L. Leibowitz, Stamatis Papathanasiou, Phillip A. Doerfler et al. · Nature Genetics · 2021 · 564 citations · Full text

, , +12

Whole chromosome loss and genomic instability in mouse embryos after CRISPR-Cas9 genome editing

Stamatis Papathanasiou, Styliani Markoulaki, Logan J. Blaine et al. · Nature Communications · 2021 · 142 citations · Full text

, , +17

Tumor necrosis factor-α confers cardioprotection through ectopic expression of keratins K8 and K18

Stamatis Papathanasiou, Steffen Rickelt, María Eugenia Soriano et al. · Nature Medicine · 2015 · 106 citations · Full text

, , +7

Heritable transcriptional defects from aberrations of nuclear architecture

Stamatis Papathanasiou, Nikos A. Mynhier, Shiwei Liu et al. · Nature · 2023 · 86 citations · Full text

, , +17

Chromothripsis as an on-target consequence of CRISPR-Cas9 genome editing

Mitchell L. Leibowitz, Stamatis Papathanasiou, Phillip A. Doerfler et al. · bioRxiv (Cold Spring Harbor Laboratory) · 2020 · 63 citations · Full text

, , +17

1–5 of 7